Table 2.
Outcome | 12 months | 24 months | Difference, 12–24 months | P value |
---|---|---|---|---|
Composite 1, Patients meeting at least 1 goal (n = 157), % (No.) | 47.1 (74) | 45.9 (72) | −1.2 | .80 |
Composite 2, Patients meeting all goals (n = 157), % (No.) | 35.7 (56) | 33 (53) | −1.9 | .66 |
HbA1c at goal (n = 58), % (No.) | 53.4 (31) | 36.2 (21) | −17.2 | .03 |
LDL at goal (n = 70), % (No) | 42.9 (30) | 47.1 (33) | 4.3 | .58 |
SBP at goal (n = 68), % (No.) | 25.0 (17) | 32.4 (22) | 7.4 | .20 |
HbA1c, (mean (SD), % | 8.3 (1.8) | 8.9 (2.1) | 0.6 | .02 |
LDL, (mean (SD), mg/dL | 111.6 (35.9) | 115.2 (45.7) | 3.6 | .51 |
SBP, (mean (SD), mm Hg | 148.4 (16.0) | 145.6 (16.1) | −2.8 | .16 |
HbA1c = hemoglobin A1c; LDL = low-density lipoprotein; SBP = systolic blood pressure.
Note: The proportions of participants reaching composite and condition-specific goals were evaluated using McNemar’s χ2 test for (paired) dichotomous outcomes and paired t-tests for continuous outcomes.